AiCuris Anti-Infective Cures AG
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.aicuris.com
Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects With Treatment Resistant Herpes Simplex Virus Type 1 or 2
- Conditions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Registration Number
- NCT05844436
Thorough QT/QTc of Pritelivir in Healthy Subjects
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 64
- Registration Number
- NCT05671029
- Locations
- 🇬🇧
Richmond Pharmacology Ltd, London, United Kingdom
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 16
- Registration Number
- NCT05513625
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 153
- Registration Number
- NCT03073967
- Locations
- 🇩🇪
Universitätsklinikum Essen, Essen, Germany
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University Arizona - Department of Medicine Arizona Health Sciences Center, Tucson, Arizona, United States
Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes
- Conditions
- Interventions
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 362
- Registration Number
- NCT02871492
Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
- First Posted Date
- 2012-08-07
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 91
- Registration Number
- NCT01658826
- Locations
- 🇺🇸
University of Texas Health Science Centre, Center for Clincial Studies, Houston, Texas, United States
🇺🇸University of Washington, Virology Research Clinic, Seattle, Washington, United States
🇺🇸Indiana University School of Medicine, IU Infectious Diseases Research, Indianapolis, Indiana, United States
Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
- Conditions
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2018-02-13
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 133
- Registration Number
- NCT01063829
- Locations
- 🇺🇸
UPMC Cancer Center, Pittsburgh, Pennsylvania, United States
🇺🇸UCLA Medical Center, Los Angeles, California, United States
🇩🇪Universitaetsklinikum Erlangen-PS, Erlangen,, Germany
Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 156
- Registration Number
- NCT01047540
- Locations
- 🇺🇸
University of Washington, Virology Research Clinic, Seattle, Washington, United States
🇺🇸University of Utah, Salt Lake City, Utah, United States
🇺🇸Indiana University School of Medicine, Office for Research, Indianapolis, Indiana, United States